These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35253756)

  • 1. Apathy Is the Best Dimension to Consider for Awareness Assessment in Alzheimer's Disease.
    Jacus JP; Voltzenlogel V; Antoine P; Cuervo-Lombard CV
    J Alzheimers Dis; 2022; 87(1):149-154. PubMed ID: 35253756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness dimensions and associated factors in Alzheimer's disease.
    Jacus JP; Voltzenlogel V; Mayelle A; Antoine P; Cuervo-Lombard CV
    Rev Neurol (Paris); 2022 Apr; 178(4):363-369. PubMed ID: 34565625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling Awareness in Alzheimer's Disease.
    Jacus JP; Mayelle A; Voltzenlogel V; Cuervo-Lombard CV; Antoine P
    J Alzheimers Dis; 2020; 76(1):89-95. PubMed ID: 32417778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness, apathy, and depression in Alzheimer's disease and mild cognitive impairment.
    Jacus JP
    Brain Behav; 2017 Apr; 7(4):e00661. PubMed ID: 28413709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment.
    Robert PH; Clairet S; Benoit M; Koutaich J; Bertogliati C; Tible O; Caci H; Borg M; Brocker P; Bedoucha P
    Int J Geriatr Psychiatry; 2002 Dec; 17(12):1099-105. PubMed ID: 12461757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caregiver rating bias in mild cognitive impairment and mild Alzheimer's disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains.
    Pfeifer L; Drobetz R; Fankhauser S; Mortby ME; Maercker A; Forstmeier S
    Int Psychogeriatr; 2013 Aug; 25(8):1345-55. PubMed ID: 23651733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Padala PR; Padala KP; Lensing SY; Ramirez D; Monga V; Bopp MM; Roberson PK; Dennis RA; Petty F; Sullivan DH; Burke WJ
    Am J Psychiatry; 2018 Feb; 175(2):159-168. PubMed ID: 28945120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Updates on anosognosia in Alzheimer's disease].
    Jacus JP; Voltzenloge V; Farrié AJ; Antoine P; Cuervo-Lombard CV
    Geriatr Psychol Neuropsychiatr Vieil; 2023 Mar; 21(1):107-115. PubMed ID: 37115686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndromic validity of apathy in Alzheimer's disease.
    Starkstein SE; Petracca G; Chemerinski E; Kremer J
    Am J Psychiatry; 2001 Jun; 158(6):872-7. PubMed ID: 11384893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caregiver perception of apathy in persons with mild cognitive impairment or Alzheimer's disease: a longitudinal study.
    Pfeifer L; Horn AB; Maercker A; Forstmeier S
    Aging Ment Health; 2017 May; 21(5):494-500. PubMed ID: 26666575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight in Alzheimer's disease and its relation to psychiatric and behavioral disturbances.
    Horning SM; Melrose R; Sultzer D
    Int J Geriatr Psychiatry; 2014 Jan; 29(1):77-84. PubMed ID: 23671016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease.
    Frakey LL; Salloway S; Buelow M; Malloy P
    J Clin Psychiatry; 2012 Jun; 73(6):796-801. PubMed ID: 22687392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.
    Rosenberg PB; Lanctôt KL; Drye LT; Herrmann N; Scherer RW; Bachman DL; Mintzer JE; ADMET Investigators
    J Clin Psychiatry; 2013 Aug; 74(8):810-6. PubMed ID: 24021498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apathy in patients with Alzheimer's disease is a cost-driving factor.
    Kruse C; Maier F; Spottke A; Bach JP; Bartels C; Buerger K; Fellgiebel A; Fliessbach K; Frölich L; Hausner L; Hellmich M; Klöppel S; Klostermann A; Kornhuber J; Laske C; Peters O; Priller J; Richter-Schmidinger T; Schneider A; Shah-Hosseini K; Teipel S; von Arnim CAF; Wiltfang J; van der Wurp H; Dodel R; Jessen F
    Alzheimers Dement; 2023 Jul; 19(7):2853-2864. PubMed ID: 36588502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
    Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
    J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anosognosia is a significant predictor of apathy in Alzheimer's disease.
    Starkstein SE; Brockman S; Bruce D; Petracca G
    J Neuropsychiatry Clin Neurosci; 2010; 22(4):378-83. PubMed ID: 21037121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Impaired Awareness and Depression, Anxiety, and Apathy in Mild to Moderate Alzheimer's Disease: A Systematic Review.
    Azocar I; Livingston G; Huntley J
    Front Psychiatry; 2021; 12():633081. PubMed ID: 33613344
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive analysis of patient and caregiver predictors for caregiver burden, anxiety and depression in Alzheimer's disease.
    Lou Q; Liu S; Huo YR; Liu M; Liu S; Ji Y
    J Clin Nurs; 2015 Sep; 24(17-18):2668-78. PubMed ID: 26108739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease.
    Nguyen JP; Suarez A; Kemoun G; Meignier M; Le Saout E; Damier P; Nizard J; Lefaucheur JP
    Neurophysiol Clin; 2017 Feb; 47(1):47-53. PubMed ID: 28161090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.